Evidence map›Paper›PMID 40857303›Full record

ArticlePloS one2025

The influence of stress hyperglycemia on consciousness disturbance and short- and long-term outcomes in stroke patients without documented diabetes: Differences between ischemic and hemorrhagic stroke.

Jing Feng, Chang He, Hongbo San, Mengsi Zhan, Hongyu Zhang, Jianheng Gu, Hongqian Fu, Jiahao Yao, Lang Li, Xuefeng Wang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jing FengDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.ORCID https://orcid.org/0009-0005-3395-7313
Chang HeDepartment of neurology, People's Hospital of Ningxiang City, Hunan, China.
Hongbo SanDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Mengsi ZhanDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Hongyu ZhangDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Jianheng GuDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Hongqian FuDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiahao YaoDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Lang LiDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Xuefeng WangDepartment of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.ORCID https://orcid.org/0009-0008-0646-8305

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough hyperglycemia is a well-known prognostic factor in diabetic stroke patients, its impact on outcomes in individuals without documented diabetes remains insufficiently explored. This study aimed to investigate the relationship between stress-induced hyperglycemia and both short- and long-term mortality, as well as impaired consciousness, in patients without documented diabetes with ischemic or hemorrhagic stroke.

methodsA retrospective cohort study was conducted using the MIMIC-IV (v3.1) database, including ICU-admitted patients without documented diabetes (ischemic or hemorrhagic stroke identified via ICD-9/10 codes). Exclusion criteria were: age < 18 years, missing glucose values, and severe impairment of consciousness upon ICU admission, defined as a Glasgow Coma Scale (GCS) score < 8. After applying these criteria, 4,151 patients were enrolled. Propensity score matching (PSM) was performed to balance baseline covariates between the hyperglycemic (HG) and non-hyperglycemic (Non-HG) groups. Cox proportional hazards models and Kaplan-Meier survival curves were used to assess the impact of hyperglycemia on mortality and neurological outcomes. Then subgroup analysis was conducted.

resultsFollowing PSM, 1,170 matched pairs were analyzed. In patients with hemorrhagic stroke (HS), stress hyperglycemia was associated with an increased 1-year mortality risk (HR = 0.71, p = 0.029). Among ischemic stroke (IS) patients, hyperglycemia independently predicted both in-hospital and 1-year mortality (HR range: 0.65-0.79, p < 0.001). Kaplan-Meier analyses showed significantly poorer survival in hyperglycemic patients. Subgroup analysis demonstrated that stress hyperglycemia was particularly detrimental in HS patients with heart failure, pneumonia, vasopressin use, or severe neurological impairment (GCS < 8 with heart failure). In IS patients, hyperglycemia was significantly associated with worse outcomes in those with advanced age, coronary artery disease, COPD, pneumonia, renal failure, or norepinephrine treatment.

conclusionStress hyperglycemia independently predicts poor outcomes in stroke without documented diabetes, especially in ischemic subtypes. These findings highlight the importance of early glycemic assessment and tailored management strategies. Further research is warranted to validate causal mechanisms. In hemorrhagic stroke, its impact appears more delayed, affecting long-term prognosis. These findings support the need for early recognition and tailored glycemic control strategies based on stroke subtype.

Indexed as

Consciousness DisordersHemorrhagic StrokeHyperglycemiaIschemic StrokeStrokeAgedFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisRetrospective StudiesStress, Physiological

Identifiers

PMID40857303
PMCPMC12380300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.